⌘K

Login Start Free

Home/Filings/4/0001468308-26-000004

4//SEC Filing

Andrade Robert 4

Accession 0001468308-26-000004

CIK 0001211583other

View on SEC.gov Company Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:28 PM ET

Size

7.3 KB

Accession

0001468308-26-000004

Insider Transaction Report

Form 4

Period: 2026-01-07

FENNEC PHARMACEUTICALS INC.FENC

CHIEF FINANCIAL OFFICER

Transactions

Exercise/Conversion
Common shares
2026-01-07$2.45/sh+14,184$34,751→ 191,100 total
Exercise/Conversion
Stock Options
2026-01-07$2.45/sh−14,184$34,751→ 836,567 total
Exercise: $2.45From: 2016-07-05Exp: 2026-07-05→ Options (14,184 underlying)

Footnotes (1)

[F1]Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.

Documents

1 file

4
form4-01072026_090120.xmlPrimary

Issuer

FENNEC PHARMACEUTICALS INC.

CIK 0001211583

Entity typeother

Related Parties

1

filerCIK 0001468308

Filing Metadata

Form type: 4
Filed: Jan 6, 7:00 PM ET
Accepted: Jan 7, 4:28 PM ET
Size: 7.3 KB

View on SEC.gov